(Senior) Medical Science Liaison Specialist - GI - HN

(Senior) Medical Science Liaison Specialist - GI - HN The ideal candidate is a passionate, self-motivated, and detail-oriented team player who is committed to the success of our customers. Then AstraZeneca might be the one for you! About AstraZeneca and AstraZeneca Vietnam AstraZeneca AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca. AstraZeneca Vietnam As a Foreign Invested Enterprise with over 700 members, AstraZeneca is investing into Vietnam 360 million USD from 2020 to 2030 with a focus on reducing the burdens of non-communicable diseases, developing local talent, and uplifting the domestic biopharmaceutical R&D and manufacturing capabilities. Over the last three decades accompanying Vietnam’s sustainable development, AstraZeneca has run several impactful programmes in collaboration with the Government, Ministry of Health and healthcare partners to promote disease awareness, prevention and early detection. In recent years, AstraZeneca Vietnam has received several certificates of merit from the Prime Minister and Minister of Health, for excellent contributions to Vietnam’s vaccine diplomacy, fight against COVID-19 and advancement of cancer treatment and disease awareness. The company has also been recognized among Vietnam’s Top 100 Best Places to Work (2018 – 2026) with various other industry awards from BritCham, EuroCham, and government agencies. What you’ll do Job Description / Capsule Field-based position responsible for implementation of activities for establishment of scientific leadership of AstraZeneca. This includes development and enhancement of professional relationships with healthcare professionals, building deep scientific understanding of AstraZeneca compounds. Driving positive opinions for the scientific and clinical value of AZ compounds for patients’ needs. Deliver medical education and clinical support to medical professionals, training sales teams and involvement in development of brand strategy. The position may also be involved in review of product materials and response to medical queries. Objective & Critical actions & Measures (QQA) External Medical & Scientific engagement 1. Build, enhance and 1maintain the engagement with scientific leaders (KEEs) • 65% of time in field engaging HCPs and external stakeholders across territory and brands • Proactively identify HCPs with high levels of scientific expertise in local treatment practice to collaborate on specific medico marketing activities • Development and implementation of KEEs engagement plan in collaboration with line manager and TA lead. Review with the line manager and MAM this plan every quarter, develop KEEs visit plan- this includes pre call visit/engagement plan with clear objective of the visit, key points discussion for the visit, data to be shared and discussed with the KEEs. • Develop own scientific knowledge for discussion on all aspects of the data to be shared with KEEs in a scientific, objective and balanced way through 1:1 discussions. Prepare for such interactions with peer group discussions. Respond to unsolicited requests for information about unapproved AZ products or unapproved uses of approved products, presenting such information in an objective, scientifically balanced, substantiated manner. Develop database of Key opinion leaders and also provide recommendations for advisory board participation • Proactively provide scientific updates and information to KEEs and identify the relevance of the data to the scientific community Quantity • 65% of available time spent meeting KEEs. (Available time = total days minus holidays, weekends, sickness) • Complete records of KEEs visits and regular review by TA Lead/line manager (define routine review as monthly for new starters and quarterly for non new starters) • Coverage/engagement of KEEs versus plan • Improvement in advocacy score Quality • Meeting skills and presentation skills based on in field coaching and 6 monthly official field assessment • annual role play assessment of capabilities and scientific knowledge – use standard assessment form and methodology • Feedback from KEEs 2. Build and maintain trust-based relationships with external stakeholders • Build AZ relationship with key external stakeholders (e.g. patient advocacy groups, key medical organisations, hospital pharmacy). Find opportunities to collaborate with such external stakeholders. Provide scientific support in CME events and through appropriate medical sponsorships/ partnership. • Act as scientific expert in the disease area(s) by presenting therapeutic updates to external stakeholders • Quantity of CMEs and Medical Sponsorship versus plan • Positive customer feedback post events 3. Develop or initiate scientific programs to explore unmet medical needs in priority disease area(s) Work with HCPs in scientific activities that help advance disease understanding such as: • Identify and recommend KEEs for Advisory Boards. • Identify potential speakers and train speakers as appropriate. • Interact in the field with the medical community in the context of various medical projects, such as clinical trials, , ESRs, scientific exchange meetings • Discuss potential involvement • Respond to unsolicited off label questions from KEEs • Able to conduct basic discussions on clinical trials in terms of study design and feasibility Quantity • No of Advisory Board Meetings versus plan • No of P2Ps/round table discussions versus plan • No of CMEs versus plan • No of ESRs communicated Quality • Cust